{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:02:32Z","timestamp":1759334552155,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jfo.2009.04.029","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T04:41:58Z","timestamp":1245213718000},"page":"511.e1-511.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Les anti-Tnf peuvent-ils induire des scl\u00e9ro-uv\u00e9ites\u00a0?"],"prefix":"10.1016","volume":"32","author":[{"given":"J.","family":"Le Garrec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mouriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2009.04.029_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0151-9638(05)79505-3","article-title":"Etanercept","volume":"132","author":"Sparsa","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jfo.2009.04.029_bib2","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.029_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis\u00a0?","volume":"87","author":"Reddy","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.029_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09273940600659393","article-title":"Etanercept (Enbrel)-associated inflammatory eye disease: case report and review of the literature","volume":"14","author":"Taban","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2009.04.029_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacity of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.029_bib6","first-page":"2727","article-title":"Ocular inflammation disease in patients with rheumatoid arthritis taking etanercept: is discontinuation of etanercept necessary\u00a0?","volume":"30","author":"Tiliakos","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2009.04.029_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.62.1.88","article-title":"Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumor necrosis factor \u03b1 inhibitors","volume":"62","author":"Kaipiainen-Seppanen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2009.04.029_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacity of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.029_bib9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2009.04.029_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.23440","article-title":"Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et al","volume":"58","author":"Scrivo","year":"2008","journal-title":". Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.029_bib11","unstructured":"Hoang-Xuan T, Robin H. Scl\u00e9rites. Encycl M\u00e9d Chir (Elsevier, Paris). Encyclop\u00e9die Pratique de M\u00e9decine. 6\u20130040, 1998, 3\u00a0p."},{"key":"10.1016\/j.jfo.2009.04.029_bib12","series-title":"Oeil et pathologies g\u00e9n\u00e9rales","first-page":"523","article-title":"Pathologie de l\u2019appareil locomoteur","author":"Weber","year":"1997"},{"key":"10.1016\/j.jfo.2009.04.029_bib13","unstructured":"Scleritis in relation to connective tissue disorders. In: Watson PG, Hazleman BL, Pavesio CE, Green WR. (Eds.) The sclera and systemic disorders. Editions Butterworth Heinemann, second edition 2004; 171\u20136."},{"key":"10.1016\/j.jfo.2009.04.029_bib14","unstructured":"Br\u00e9zin A. Examen clinique et explorations compl\u00e9mentaires en pr\u00e9sence d\u2019une uv\u00e9ite, \u00e9l\u00e9ments d\u2019orientation diagnostique. Encycl M\u00e9d Chir (Elsevier, Paris), Ophtalmologie, 21-220-A20, 1998, 15p."},{"key":"10.1016\/j.jfo.2009.04.029_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1358\/dot.2003.39.11.799461","article-title":"Ocular side effects associated with biphosphonates","volume":"39","author":"Fraunfelder","year":"2003","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.jfo.2009.04.029_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.SMJ.0000152753.80490.9F","article-title":"Biphosphonate-associated scleritis: a case report and review","volume":"98","author":"Leung","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.jfo.2009.04.029_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","article-title":"Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.04.029_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1358\/dot.2007.43.2.1050789","article-title":"Drug-induced ocular inflammatory diseases","volume":"43","author":"Fraunfelder","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jfo.2009.04.029_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","article-title":"Ocular adverse effects associated with systemic medications: recognition and management","volume":"67","author":"Santaella","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jfo.2009.04.029_bib20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/art.23442","article-title":"Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et al","volume":"58","author":"Sfikakis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.029_bib21","first-page":"1100","article-title":"Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat","volume":"35","author":"De Vos","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2009.04.029_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0014-4835(05)80017-X","article-title":"Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin\u2013induced uveitis in the rat","volume":"61","author":"De Vos","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2009.04.029_bib23","first-page":"2911","article-title":"The paradoxical effect of tumor necrosis factor alpha (TNF\u03b1) in endotoxin-induced uveitis","volume":"34","author":"Kasner","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:00:27Z","timestamp":1759258827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551209002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0181551209002034"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2009.04.029","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les anti-Tnf peuvent-ils induire des scl\u00e9ro-uv\u00e9ites\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2009.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}